Sharon Shacham
2014
In 2014, Sharon Shacham earned a total compensation of $534.3K as President and Chief Scientific Officer at Karyopharm Therapeutics, a 93% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,500 |
|---|---|
| Salary | $385,000 |
| Other | $10,820 |
| Total | $534,320 |
Shacham received $385K in salary, accounting for 72% of the total pay in 2014.
Shacham also received $138.5K in non-equity incentive plan and $10.8K in other compensation.
Rankings
In 2014, Sharon Shacham's compensation ranked 10,058th out of 13,032 executives tracked by ExecPay. In other words, Shacham earned more than 22.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,058 out of 13,032 | 23rd |
Division Manufacturing | 3,822 out of 4,965 | 23rd |
Major group Chemicals And Allied Products | 1,313 out of 1,690 | 22nd |
Industry group Drugs | 1,049 out of 1,369 | 23rd |
Industry Pharmaceutical Preparations | 805 out of 1,042 | 23rd |
Source: SEC filing on April 29, 2016.
Shacham's colleagues
We found four more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2014.
2014
Justin Renz
Karyopharm Therapeutics
Chief Financial Officer
2014
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Worldwide Development Operations
2014
Christopher Primiano
Karyopharm Therapeutics
General Counsel
2014
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019